Serum lactate dehydrogenase isoenzyme 1 as a prognostic predictor for metastatic testicular germ cell tumours.
作者信息
von Eyben F E, Madsen E L, Liu F, Amato R, Fritsche H
出版信息
Br J Cancer. 2000 Nov;83(9):1256-9. doi: 10.1054/bjoc.2000.1449.
Abstract
摘要
相似文献
1
Serum lactate dehydrogenase isoenzyme 1 as a prognostic predictor for metastatic testicular germ cell tumours.血清乳酸脱氢酶同工酶1作为转移性睾丸生殖细胞肿瘤的预后预测指标
Br J Cancer. 2000 Nov;83(9):1256-9. doi: 10.1054/bjoc.2000.1449.
2
A systematic review of lactate dehydrogenase isoenzyme 1 and germ cell tumors.乳酸脱氢酶同工酶1与生殖细胞肿瘤的系统评价。
Clin Biochem. 2001 Sep;34(6):441-54. doi: 10.1016/s0009-9120(01)00236-3.
3
4
It is rational to measure serum lactate dehydrogenase isoenzyme-1 activity in patients with testicular germ cell tumours.对睾丸生殖细胞肿瘤患者测量血清乳酸脱氢酶同工酶-1活性是合理的。
Eur J Clin Chem Clin Biochem. 1997 Dec;35(12):943.
5
High lactate dehydrogenase isoenzyme 1 in a patient with malignant germ cell tumor is attributable to aberrant methylation of the LDHA gene.
Clin Chem. 2004 Oct;50(10):1826-8. doi: 10.1373/clinchem.2004.037739. Epub 2004 Aug 5.
6
Serum lactate dehydrogenase isoenzyme 1 and prediction of death in patients with metastatic testicular germ cell tumors.血清乳酸脱氢酶同工酶1与转移性睾丸生殖细胞肿瘤患者死亡的预测
Clin Chem Lab Med. 2001 Jan;39(1):38-44. doi: 10.1515/CCLM.2001.010.
7
Lactate dehydrogenase isoenzyme 1 is the most important LD isoenzyme in patients with testicular germ cell tumor.
Acta Oncol. 2000;39(4):509-17. doi: 10.1080/028418600750013438.
8
9
A new prognostic model for testicular germ cell tumours.一种用于睾丸生殖细胞肿瘤的新预后模型。
APMIS. 2003 Jan;111(1):100-5; discussion 105. doi: 10.1034/j.1600-0463.2003.1110114_1.x.
10
Absence of sperm-specific lactate dehydrogenase-x in patients with testis cancer.睾丸癌患者中缺乏精子特异性乳酸脱氢酶-x。
Oncodev Biol Med. 1982;3(4):269-72.
引用本文的文献
1
Utility of serum and salivary lactate dehydrogenase and uric acid levels as a diagnostic profile in oral squamous cell carcinoma patients.血清和唾液乳酸脱氢酶及尿酸水平作为口腔鳞状细胞癌患者诊断指标的效用
J Oral Maxillofac Pathol. 2022 Apr-Jun;26(2):218-227. doi: 10.4103/jomfp.jomfp_26_22. Epub 2022 Jun 28.
2
Correlation analysis of serum cystatin C, uric acid and lactate dehydrogenase levels before chemotherapy on the prognosis of small-cell lung cancer.化疗前血清胱抑素C、尿酸和乳酸脱氢酶水平与小细胞肺癌预后的相关性分析
Oncol Lett. 2021 Jan;21(1):73. doi: 10.3892/ol.2020.12334. Epub 2020 Nov 25.
3
Prognostic value of D-lactate dehydrogenase in patients with clear cell renal cell carcinoma.D-乳酸脱氢酶在透明细胞肾细胞癌患者中的预后价值。
Oncol Lett. 2018 Jul;16(1):866-874. doi: 10.3892/ol.2018.8782. Epub 2018 May 22.
4
Quantitative Characterization of the Exposure-Response Relationship for Cancer Immunotherapy: A Case Study of Nivolumab in Patients With Advanced Melanoma.癌症免疫治疗暴露-反应关系的定量表征：以纳武利尤单抗治疗晚期黑色素瘤患者为例
CPT Pharmacometrics Syst Pharmacol. 2017 Jan;6(1):40-48. doi: 10.1002/psp4.12133. Epub 2016 Dec 26.
5
Overall survival of cancer patients with serum lactate dehydrogenase greater than 1000 IU/L.血清乳酸脱氢酶大于1000 IU/L的癌症患者的总生存期。
Tumour Biol. 2016 Oct;37(10):14083-14088. doi: 10.1007/s13277-016-5228-2. Epub 2016 Aug 10.
Zotero 插件